• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.44% Nasdaq Down 0.33%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    3.98 Down 0.03(0.75%) 10:51AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.01
    Open:4.00
    Bid:3.96 x 9000
    Ask:3.97 x 3900
    1y Target Est:7.08
    Beta:-4.69
    Earnings Date:Jul 30 - Aug 3 (Est.)
    Day's Range:3.90 - 4.02
    52wk Range:3.26 - 6.59
    Volume:846,150
    Avg Vol (3m):3,774,390
    Market Cap:963.28M
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 0.75%963.28M
    GSKDown 0.36%107.35B
    OREXDown 1.42%601.32M
    RHHBYUp 1.11%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):26.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.52
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback